Market Insights Health OTC Pharmaceuticals

Digestives & Intestinal Remedies - Benelux

Benelux

In Benelux, the Digestives & Intestinal Remedies market market generates a revenue of US$242.30m in 2024.
It is projected to experience an annual growth rate of 1.50% (CAGR 2024-2029).
When compared globally, in China leads the market with a revenue of US$4,408.00m in 2024.
Looking at the per person basis, in Benelux, each individual generates US$8.06 in revenue in 2024.
In the Benelux region, there is a growing trend towards natural and herbal remedies for digestive issues, with consumers seeking alternative options to traditional OTC pharmaceuticals.

Key regions: Canada, United States, Australia, Brazil, Japan

Market

Region

Region comparison

Currency

Analyst Opinion

The Digestives & Intestinal Remedies market in Benelux is experiencing significant growth due to changing customer preferences and the emergence of new trends in the market. Customer preferences in the Digestives & Intestinal Remedies market in Benelux are shifting towards natural and herbal remedies. Consumers are increasingly seeking products that are made from natural ingredients and have fewer side effects. This preference for natural remedies is driven by a growing awareness of the potential harmful effects of synthetic ingredients and a desire for more holistic approaches to health and wellness. As a result, there is a rising demand for digestive supplements and remedies that are derived from plants and herbs.Trends in the Digestives & Intestinal Remedies market in Benelux are also influenced by global and regional market developments. One of the key trends is the increasing focus on gut health and the gut-brain connection. Research has shown that a healthy gut is essential for overall well-being, and this has led to a surge in demand for products that support digestive health. Probiotics, prebiotics, and other gut-friendly ingredients are becoming more popular as consumers seek to improve their digestive function and overall health.Another trend in the market is the rise of functional foods and beverages. Consumers are looking for products that not only provide relief from digestive issues but also offer additional health benefits. This has led to the development of a wide range of functional foods and beverages that contain digestive enzymes, fiber, and other ingredients that promote digestive health. These products are seen as convenient and easy ways to incorporate digestive remedies into daily routines.In addition to changing customer preferences and global trends, there are also local special circumstances that are influencing the Digestives & Intestinal Remedies market in Benelux. The region has a high prevalence of digestive disorders, such as irritable bowel syndrome and gastroesophageal reflux disease. This has created a large and growing market for digestive remedies, as consumers seek relief from these conditions. Furthermore, the Benelux region has a well-developed healthcare system and a high level of consumer awareness about health and wellness. This creates a favorable environment for the growth of the Digestives & Intestinal Remedies market.Underlying macroeconomic factors are also contributing to the growth of the Digestives & Intestinal Remedies market in Benelux. The region has a stable economy and a high standard of living, which allows consumers to prioritize their health and well-being. Additionally, the aging population in Benelux is driving demand for digestive remedies, as older individuals are more prone to digestive issues and are seeking ways to manage their symptoms.Overall, the Digestives & Intestinal Remedies market in Benelux is experiencing growth due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. The market is expected to continue expanding as consumers prioritize digestive health and seek natural and holistic solutions to their digestive issues.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.